133 related articles for article (PubMed ID: 38051169)
21. From part to whole, operative link on to endoscopic grading of gastric intestinal metaplasia, pathology to endoscopy: gastric intestinal metaplasia graded by endoscopy.
Wei N; Zhou M; Lei S; Yang L; Duan Z; Zhang Y; Zhong Z; Liu Y; Shi R
Future Oncol; 2022 Jun; 18(19):2445-2454. PubMed ID: 35574611
[No Abstract] [Full Text] [Related]
22. The risk of gastric cancer in patients with gastric intestinal metaplasia in 5-year follow-up.
Pittayanon R; Rerknimitr R; Klaikaew N; Sanpavat A; Chaithongrat S; Mahachai V; Kullavanijaya P; Barkun A
Aliment Pharmacol Ther; 2017 Jul; 46(1):40-45. PubMed ID: 28449219
[TBL] [Abstract][Full Text] [Related]
23. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
24. Cytosponge-TFF3 Testing can Detect Precancerous Mucosal Changes of the Stomach.
Hadjinicolaou AV; Azizi AA; O'Donovan M; Debiram I; Fitzgerald RC; Di Pietro M
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1411-1412. PubMed ID: 34358719
[TBL] [Abstract][Full Text] [Related]
25. International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk.
Ascherman B; Oh A; Hur C
Gastric Cancer; 2021 Jul; 24(4):878-887. PubMed ID: 33595744
[TBL] [Abstract][Full Text] [Related]
26. Index diagnoses of gastric intestinal metaplasia in the United States: patient characteristics, endoscopic findings, and clinical practice patterns at a large tertiary care center.
Parbhu SK; Shah SC; Sossenheimer MJ; Fang JC; Peterson KA; Gawron AJ
Therap Adv Gastroenterol; 2022; 15():17562848221117640. PubMed ID: 36082176
[TBL] [Abstract][Full Text] [Related]
27. Gastric intestinal metaplasia - age, ethnicity and surveillance for gastric cancer.
Simko V; Anand N; Ginter E
Bratisl Lek Listy; 2015; 116(1):3-8. PubMed ID: 25666954
[TBL] [Abstract][Full Text] [Related]
28. Magnifying endoscopy with narrow-band imaging for diagnosis of subtype of gastric intestinal metaplasia.
Kanemitsu T; Uedo N; Ono T; Nimura S; Hasegawa R; Imamura K; Ohtsu K; Ono Y; Miyaoka M; Ueki T; Tanabe H; Ohta A; Iwashita A; Yao K
J Gastroenterol Hepatol; 2023 Jan; 38(1):94-102. PubMed ID: 36268636
[TBL] [Abstract][Full Text] [Related]
29. A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk.
Zhou HJ; Dan YY; Naidoo N; Li SC; Yeoh KG
PLoS One; 2013; 8(12):e83959. PubMed ID: 24386314
[TBL] [Abstract][Full Text] [Related]
30. Clinical epidemiology and outcomes of patients with gastric intestinal metaplasia in the Los Angeles County System.
Prakash P; Jain S; Trieu H; Chow K; Karunasiri D; Liang T; Yung E; Mason H; Tan H; Tabibian JH
BMC Gastroenterol; 2023 May; 23(1):165. PubMed ID: 37208616
[TBL] [Abstract][Full Text] [Related]
31. Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia.
Savarino E; Corbo M; Dulbecco P; Gemignani L; Giambruno E; Mastracci L; Grillo F; Savarino V
World J Gastroenterol; 2013 May; 19(17):2668-75. PubMed ID: 23674874
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis.
Kapoor R; So JBY; Zhu F; Too HP; Yeoh KG; Yoong JS
Value Health; 2020 Sep; 23(9):1171-1179. PubMed ID: 32940235
[TBL] [Abstract][Full Text] [Related]
33. Comparing endoscopy and upper gastrointestinal X-ray for gastric cancer screening in South Korea: a cost-utility analysis.
Chang HS; Park EC; Chung W; Nam CM; Choi KS; Cho E; Cho WH
Asian Pac J Cancer Prev; 2012; 13(6):2721-8. PubMed ID: 22938448
[TBL] [Abstract][Full Text] [Related]
34. Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.
Wu JT; Zhou J; Naidoo N; Yang WY; Lin XC; Wang P; Ding JQ; Wu CB; Zhou HJ
Asia Pac J Clin Oncol; 2016 Dec; 12(4):359-368. PubMed ID: 27452189
[TBL] [Abstract][Full Text] [Related]
35. Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population.
Tan MC; Ho Q; Nguyen TH; Liu Y; El-Serag HB; Thrift AP
Dig Dis Sci; 2022 Sep; 67(9):4500-4508. PubMed ID: 34797447
[TBL] [Abstract][Full Text] [Related]
36. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
[TBL] [Abstract][Full Text] [Related]
37. Screening and surveillance for gastric cancer in the United States: Is it needed?
Kim GH; Liang PS; Bang SJ; Hwang JH
Gastrointest Endosc; 2016 Jul; 84(1):18-28. PubMed ID: 26940296
[TBL] [Abstract][Full Text] [Related]
38. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.
Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G
JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889
[TBL] [Abstract][Full Text] [Related]
39. Association of endoscopic biopsy sampling methods with detection of precursor lesions of gastric cancer.
Moon RH; Puttock EJ; Chen W; Luong TQ; Wu BU
Gastrointest Endosc; 2024 Feb; 99(2):204-213.e5. PubMed ID: 37717603
[TBL] [Abstract][Full Text] [Related]
40. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.
Shah SC; Piazuelo MB; Kuipers EJ; Li D
Gastroenterology; 2021 Oct; 161(4):1325-1332.e7. PubMed ID: 34454714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
